Biotech Week articles from June 2004

Biotech Week archives from June 2004

FDA clearance granted for Amplatzer Vascular Plug.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- AGA Medical Corporation has received clearance from the U.S. Food and Drug Administration for its Amplatzer Vascular Plug, an implantable device that provides physicians with a minimally invasive...

Device company implants 13th AbioCor replacement heart.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Abiomed, Inc., (ABMD) announced the 13th implantation of the AbioCor Implantable Replacement Heart. The implant was performed on May 3 in Louisville, KY by a Jewish Hospital/University of...

Results of trial evaluating use of eculizumab presented at hematology meeting.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced that Peter Hillmen, MB ChB, PhD, consultant hematologist of The General Infirmary at Leeds, Leeds, U.K., presented the cumulative 1 year results of an...

Data highlight positive effect of Namenda on brain activity in AD patients.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) announced the results of a randomized, placebo-controlled, PET (positron emission tomography) imaging pilot study designed to measure the effect that Namenda (memantine...

Researcher finds genetic explanations for some previously unexplained deaths.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Imagine walking down the street, collapsing without warning and dying within minutes. According to the American Heart Association, about 250,000 Americans suffer sudden cardiac death each year, and half...

Agreement signed to develop compounds for autoimmune disorders.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- 4SC AG, a German-based drug discovery and development company, and Serono (virt-x: SEO and SRA) announced that they have signed an agreement under which 4SC grants Serono exclusive worldwide rights to...

Pharmaceutical firm files shelf registration statement.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- A.P. Pharma, Inc., (APPA) announced that it has filed a shelf registration statement with the U.S. Securities and Exchange Commission covering up to $15,000,000 of its common stock. The specific...

Company seeks partner for Immunogene therapy for cancer.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- AMDL, Inc., (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced that it has launched a major effort to seek a strategic partner for clinical...

Pharmaceutical company reports loss of $0.21 per share.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) reported financial results for the 3 months ended March 31, 2004. For the first quarter of 2004, AVI reported a net loss of $7.5 million, or $0.21 per share, compared...

Personal interviews aid study of binge drinking during pregnancy.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- To study the adverse effects of binge drinking during pregnancy, researchers found personal interviews with women in their study cohort were more effective than self-administered questionnaires. ...

The international prostate symptom questionnaire can be self-administered.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Study finds no significant differences in score when the international prostate symptom score (IPSS) questionnaire was administered by a physician or self-administered, researchers say. According...

Mammalian target of rapamycin regulates IRS-1 serine phosphorylation.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- A mammalian target of rapamycin regulates insulin receptor substrate (IRS)-1 serine 307 phosphorylation. According to published research from the United States, "Insulin signaling can be negatively...

Positive opinion granted by EU for Humira.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories announced that the European Medicines Evaluation Agency (EMEA) has granted a positive opinion for Humira (adalimumab) label extension for reducing the rate of progression of joint...

FDA approval granted for Theophylline tablets.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX) announced that it has received U.S. Food and Drug Administration (FDA) approval for its Abbreviated New Drug Applications for Theophylline Extended-Release Tablets, 300mg...

Rab6 membrane association dependent on cellular phosphorylation events.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Rab6 membrane association is dependent on Presenilin 1 and cellular phosphorylation events. "Processing of the amyloid precursor protein (APP) by alpha-secretase precludes the formation of...

Systemic treatment of esophageal cancer reviewed.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Scientists review systemic treatment of esophageal cancer in a recent issue of the European Journal of Gastroenterology and Hepatology. "Most patients with esophageal cancer present with locally...

Pharmacy provider reports earnings of $0.43 per share.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Accredo Health, Inc., (ACDO) reported record results for its third quarter ended March 31, 2004. Net earnings were $21.1 million or $0.43 per diluted share, for the quarter ended March 31, 2004....

Biopharmaceutical firm closes $40M series B financing.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Acologix, Inc., announced the closing of its Series B financing of nearly $40 million. The financing was led by Nomura Securities Co., Ltd., of Tokyo. Participating in the round as new investors...

Pharmaceutical company reports financial results, clinical update.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Acusphere, Inc., (ACUS), a specialty pharmaceutical company, reported financial results for the quarter ended March 31, 2004, and commented on the operational progress of its lead product candidate,...

First part of NDA submitted for Entereg.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) announced that it has submitted the first portion of its New Drug Application (NDA) for Entereg for the management of postoperative ileus (POI). The submission was made...

Agreement signed for humanized antibody to interferon-gamma.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Advanced Biotherapy, Inc., (ADVB) and Innogenetics NV (INNX) announced the signing of a cross-licensing agreement combining Innogenetics' patented humanized antibody to interferon-gamma (known as INNO...

Licensing agreement signed with Quest Vision.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Advanced Medical Optics, Inc., (AMO, AVO) announced a 1-year research and evaluation licensing agreement with Quest Vision Technologies, Inc., to develop accommodating intraocular lens (IOL) designs....

Device firm announces ISO 13485:2003 certification.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Aerogen, Inc., (AEGN) announced that its facilities in both Mountain View, California, and Galway, Ireland, have recently been registered to the international quality standard ISO 13485:2003 titled...

Biotech company expands management team.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Affymax, Inc., announced that it has strengthened its management team with the addition of Robert B. Naso, PhD, as executive vice president of research and development, the appointment of Gene F....

Pharmaceutical companies enter development, manufacturing agreement.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Akorn, Inc., (OB) announced that it has entered into a development and manufacturing agreement with Aero Pharmaceutical, Inc., to provide contract manufacturing services. Akorn and Aero intend to...

Intraocular lens provide near, distance vision after cataract removal.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Alcon, Inc., (ACL) reported updated clinical results on the AcrySof ReSTOR intraocular lens (IOL) that demonstrate its ability to substantially restore a cataract patient's ability to see both near and...

Increased atopy caused by development of Th2 immune response to allergens.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Increased atopy may be caused by the development of a Th2 immune response to environmental allergens. "Developed nations are experiencing a marked increase in prevalence of the familial allergic...

Imaging company reports 2.8% increase in revenue.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Alliance Imaging, Inc., (AIQ) announced results for the first quarter ended March 31, 2004. Revenue increased 2.8% to $105.6 million for the first quarter ended March 31, 2004, from revenue of...

Pharmaceutical company reports loss of $0.06 per share.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO) announced a diluted loss per share of $0.06 for the first quarter of 2004. During the first quarter, the company recorded severance charges associated with business...

Chiropractors comment on new ear infection guidelines.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- The American Chiropractic Association (ACA) praised the American Academy of Pediatrics (AAP) for releasing new, conservative guidelines for treating children with ear inflammation, but added that...

New data show how 6-nitrochrysene shapes mammary carcinogenesis and mutagenesis.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- New data show how 6-nitrochrysene shapes mammary carcinogenesis and mutagenesis. According to researchers in the United States, "we determined the mutant fractions (MF) and mutational specificities...

FDA clears new vaginal vault prolapse repair system.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- American Medical Systems Holdings Inc. (Nasdaq:AMMD) announced that its Apogee System has received U.S. Food and Drug Administration clearance. The company also announced it will begin physician...

Soybean protein peptide may inhibit growth of tumor cells.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- American Oriental Bioengineering, Inc., announced findings that soybean protein peptide may inhibit the growth of tumor cells. Research conducted at American Oriental Bioengineering's research...

African Americans are at greater risk for stroke than other ethnic groups.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- According to the American Stroke Association, a division of the American Heart Association, African Americans are at greater risk of death from cardiovascular disease and stroke than any other ethnic...

Colorectal cancer incidence is increasing in Japan.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Trends show colorectal cancer is increasing in Japan and is now similar to the rates in the U.S., researchers say. "We examined trends of colorectal cancer incidence rates among Japanese (Miyagi...

Cytokines IL-8 and IL-10 are prognostic factors in burn sepsis.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Cytokines IL-8 and IL-10 are prognostic factors in burn sepsis. Scientists in Turkey report, "Cytokines have been considered as important participants in the post-burn pathophysiological process....

Radiation improves survival in node-positive breast cancer patients.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Postmastectomy radiotherapy improves overall survival in node-positive breast cancer patients. "Postmastectomy irradiation substantially reduces the risk of locoregional recurrences (LRR) of breast...

High-protein, low-fat diets effective for weight loss.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- High-protein, low-fat diets are effective for weight loss and favorably alter biomarkers in healthy adults. "Although popular and effective for weight loss, low-carbohydrate, high-protein, high-fat...

Majority investment made in new nanotech subsidiary.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Arrowhead Research Corp. (ARWR), an emerging company in the field of nanotechnology, announced that it has agreed to take a majority position in Insert Therapeutics, Inc., a Pasadena-based company...

Pennington scientists turn human fat cells into bone.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Calling human fat a new and more abundant source of adult stem cells, Pennington Biomedical Research Center scientists have witnessed human fat stem cells convert into bone when slipped under the skin...

Acute urinary retention can affect quality of life for patients.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Study reviews acute urinary retention (AUR), but more research is needed to discover ways to prevent it. "Acute retention of urine is a common urological emergency characterized by a sudden...

Human and rat glucokinase regulatory proteins compared.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Researchers compare the differences in regulatory properties of the human and rat glucokinase regulatory proteins in a recent issue of the Biochemical Journal. "The inhibition of glucokinase by rat...

Humana joins with drugmaker to improve cholesterol-lowering drug compliance.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Humana, Inc., (HUM) and AstraZeneca (AZN) will conduct a joint study to evaluate how technology can improve patient medication compliance. This study will measure how voice activated technology...

Studies examine Seroquel monotherapy remission rates in bipolar mania.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- AstraZeneca (AZN) announced data at the American Psychiatric Association's annual meeting from a pooled analysis of two double-blind, placebo-controlled studies that examined the effectiveness of...

Survey: Lack of public awareness about strokes related to AF.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Results from a new national survey conducted by the not-for-profit Alliance for Aging Research to mark National Stroke Awareness Month show that about 80% of a thousand people polled were not aware...

CpG is not effective adjuvant to Toxoplasma gondii vaccination.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- CpG is not an effective adjuvant to Toxoplasma gondii vaccination. "Unmethylated CpG dinucleotides have been found to stimulate general immune responses in mammals. CpG motifs have further been...

Changing IVIG preparations increases risk of adverse effects.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Changing intravenous immunoglobulin (IVIG) preparations can lead to an increased risk of adverse effects. IVIG therapy "has represented a major advance in the treatment of patients with primary...

Vaccinia virus encoding T-cell chemoattractant is attenuated in vivo.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo. According to recent research from Australia, "Murine interferon-inducible T-cell...

Too much testosterone blights social skills.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Levels of testosterone in the womb may have profound effects on a person's social development. The findings might also explain why men are four times as likely as women to suffer from autism. The...

Reproducibility of diabetes diagnosis in women reported.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Investigators report the reproducibility of a diabetes diagnosis in women using the World Health Organization (WHO) 1999 criteria. "Reproducibility of diabetes mellitus (DM) diagnosis has been...

HDCT improves cure rate of young children with medulloblastoma and stPNET tumors.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- High-dose chemotherapy improves cure rate of young children with medulloblastoma and supratentorial primitive neuroectodermal tumors. "In order to improve the dismal prognosis of patients younger...

Encouraging data reported from phase I study of asthma/allergy drug.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Avanir Pharmaceuticals (AVN) announced the completion of the initial phase I clinical trial for its experimental asthma/allergy drug, AVP 13358. The study included 54 healthy volunteers and was...

Group B meningococcal vaccine safe but not effective in men.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- A group B meningococcal N-propionylated polysaccharide conjugate vaccine was safe in adult, male volunteers, but did not appear to be efficacious. According to recent research published in the...

FDA issues not approvable letter for OTC "morning after" pill.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has issued a "Not Approvable" letter to the sponsor of an application to make the Plan B emergency contraception product available without a prescription. ...

Intranasal influenza vaccine causes facial paralysis.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- The intranasal influenza vaccine caused facial paralysis in a working population in Switzerland. According to recent research from Switzerland, "In the present study, we assessed the incidence of...

Third-generation vaccine against smallpox tested.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Not everybody can safely be vaccinated against smallpox using the current U.S. Food and Drug Administration-approved vaccine. Scientists hope another study vaccine, now undergoing its first testing...

Imvamune smallpox vaccine clinical study to include eczema patients.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Bavarian Nordic A/S announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug application (IND) for its third-generation smallpox vaccine candidate...

Data: Avelox remains active against bacterial strains.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- North American surveillance data presented at the 14th annual European Congress of Clinical Microbiology and Infectious Diseases showed the antibiotic Avelox (moxifloxacin HCl) was still active against...

Avelox benefits study patients with community-acquired pneumonia.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- A study presented at the 14th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) showed that hospitalized patients with community-acquired pneumonia (CAP) who received...

Insulin-like growth factor works on several levels for nerve regeneration.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Insulin-like growth factor works on several levels for nerve regeneration. According to published research from the United States, "the elements of peripheral nerve regeneration comprise a complex...

Low-density lipoprotein reduction is key to cardiovascular disease prevention.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Efforts to lower low-density lipoprotein cholesterol (LDL-C) below current recommended levels may have additional benefit in preventing coronary heart disease (CHD), researchers report. "Current...

Several factors associated with chronic pelvic pain.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- The etiology of interstitial cystitis, a common problem in women, may involve several factors, all that result in reducing quality of life. "Interstitial cystitis (IC) is chronic pelvic pain of...

New study reports on achieving pharmaceutical brand leadership.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Modifying treatment guidelines can propel pharmaceutical brands to No. 1 in market share, according to 75% of surveyed executives in a new study from pharmaceutical research firm Best Practices, LLC....

Mouse cardiac surgery techniques described.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Researchers describe techniques for performing mouse cardiac surgery with regard to genomic studies. "Mouse models mimicking human diseases are important tools in trying to understand the...

Drug development company announces founding investors.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- BioLineRx Ltd. announced the addition of Star Ventures and Yehuda Zisapel to its group of founding investors. The investment raises the initial capital committed by its founders to approximately...

Amevive (alefacept) approved in Israel.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Biogen Idec (BIIB) announced that the Israeli Ministry of Health has approved Amevive (alefacept) for sale in Israel for treatment of adult patients with moderate-to-severe chronic plaque psoriasis who...

Increased islet mass is linked to decreased islet blood flow during pregnancy.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Increased islet mass is linked to decreased islet blood flow during pregnancy. "Increased blood perfusion of pancreatic islets is seen during various conditions of increased demand for insulin...

Pharmaceutical company reports earnings of $0.13 per share.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Biovail Corporation (BVF) (BVF) announced its financial results for the 3-month period ending March 31, 2004. Total revenues for the 3 months ended March 31, 2004, were $186.6 million versus $191.4...

Melanin-concentrating hormone antagonists are novel anti-obesity agents.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Melanin-concentrating hormone antagonists are novel anti-obesity agents. "The discovery in the mid 1990s that melanin-concentrating hormone (MCH) is a strong appetite stimulant has led to a rapid...

FDA grants approval for new indication for Hectorol.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Bone Care International, Inc., (BCII) announced that the U.S. Food and Drug Administration approved a new indication and strength for Hectorol (doxercalciferol) capsules. Hectorol, a novel...

Role of diet relapses in dieting investigated.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Diet relapses play an important role in dieting success. "Much of the research on relapse crises in dieting has focused on isolated lapse events and relied heavily on retrospective self-report...

Pediatric dengue vaccine is cost-effective.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- A pediatric dengue vaccine is cost-effective in Southeast Asia. According to published research from the United States, "To ascertain the economic feasibility of a pediatric tetravalent dengue...

Studies on screening and treatment for bone loss are hard to compare.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- When researchers at Brigham & Women's Hospital conducted a literature review for studies of bone mineral density testing and osteoporosis treatments, they found, instead, a lot of apples and oranges....

gamma-Secretase complex has physiological role in neuronal development.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- gamma-Secretase complex has a physiological role in neuronal development. According to scientists writing in the Journal of Neuroscience, "gamma-Secretase is a multimeric complex consisted of...

Pharmaceutical company reports $0.49 per share earnings.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) reported net earnings of $964 million on sales of $5.2 billion for the first quarter of 2004. Fully diluted earnings per share for the quarter were $.49....

Botulinum toxin structure offers clues for vaccines/treatments.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- By deciphering the near-atomic-level structure of the catalytic domain of botulinum toxin type E - one of seven neurotoxins that cause botulism, a disease that paralyzes victims by blocking nerve cells'...

Device firm closes common stock offering.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Bruker BioSciences Corporation (BRKR) announced the closing of its public offering of 17,250,000 shares of its common stock, of which 3,450,000 shares were sold by the company and 13,800,000 shares were...

Proteins modulated during neuronal hypoxia identified.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Proteins with altered expression during neuronal hypoxia have been identified. In a recent study, researchers in California "used high-throughput Western blotting to identify proteins that are up-...

Fear of SARS had strong impact on access to health care.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- A fear of SARS had a strong impact on access to healthcare. "Using interrupted time-series analysis and National Health Insurance data between January 2000 and August 2003, this study assessed the...

Beta-catenin regulates the gene of unique novel matrix metalloproteinase-26.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Beta-catenin regulates the gene of unique novel matrix metalloproteinase-26. "There are several unorthodox features, which distinguish the non-redundant and unique novel matrix metalloproteinase-26...

NERD is DNA processing-related domain in anthrax virulence plasmid.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- NERD is a DNA processing-related domain present in the anthrax virulence plasmid, pXO1. "We have identified a new domain in a broad range of bacterial, as well as single archaeal and plant...

Device firm reports 7% increase in net sales.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- CAS Medical Systems, Inc., (CAMY) announced financial results for the 3 months ended March 31, 2004. Net sales for the company's first quarter ended March 31, 2004, totaled $4,516,000, a 7%...

"User-friendly" scoring index for clinical use identifies risk of bone loss.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Medical researchers in Belgium have developed a clinical scoring index that identifies a patient's level of osteoporosis risk. J.Y. Reginster and colleagues, CHU Center Ville, Bone & Cartilage...

Consumer healthcare products company reports 10% sales growth.
June 2, 2004... 2004 JUN 2 - (NewsRx.com & NewsRx.net) -- CNS, Inc., (CNXS), the Breathe Right company, announced results for the fiscal year and fourth quarter ended March 31, 2004. For the full year 2004, CNS' net sales grew 10% to a record $87.0...